AQP6 (KID) as A Potential Drug Target and Biomarker (G363)

Target Name: AQP6

NCBI ID: G363

AQP6

AQP6 (KID) as A Potential Drug Target and Biomarker

AQP6 (KID), also known as Aquaporin 6, is a water channels protein that is expressed in various body tissues and organs, including the brain, lungs, heart, kidneys, and intestines. It plays a crucial role in the regulation of water and electrolyte balance in the body, and is involved in a wide range of physiological processes that are essential for proper growth, development, and survival.

Recent studies have identified AQP6 (KID) as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, diabetes, and cardiovascular diseases. The unique properties of AQP6 (KID), such as its high expression in the brain and its role in water homeostasis, make it an attractive target for drug development.

One of the key advantages of AQP6 (KID) as a drug target is its potential to modulate a wide range of physiological processes that are involved in the development and progression of many diseases. For example, AQP6 (KID) has been shown to be involved in the regulation of neurotransmitter release and uptake, which is important for the function of the brain and other nervous system cells. Additionally, AQP6 (KID) is involved in the regulation of ion and water transport, which is critical for maintaining the proper balance of electrolytes in the body.

In neurodegenerative disorders, AQP6 (KID) has been shown to be involved in the regulation of neurotransmitter release and uptake, as well as the proper functioning of neural circuits. For example, studies have shown that AQP6 (KID) is involved in the regulation of dopamine release and uptake in Parkinson's disease, and that it plays a role in the progression of neurodegeneration in this disease. Similarly, AQP6 (KID) has also been shown to be involved in the regulation of ion transport in the brain, which is important for maintaining the proper balance of electrolytes in the brain.

In addition to its potential role in neurodegenerative disorders, AQP6 (KID) has also been shown to be involved in the regulation of other physiological processes that are important for overall health and disease risk. For example, AQP6 (KID) has been shown to be involved in the regulation of blood pressure, which is important for maintaining proper cardiovascular function. Additionally, AQP6 (KID) has been shown to be involved in the regulation of body temperature, which is critical for maintaining proper physiological function in the body.

As a potential biomarker, AQP6 (KID) has been shown to be involved in the diagnosis and progression of various diseases, including neurodegenerative disorders, diabetes, and cardiovascular diseases. For example, studies have shown that AQP6 (KID) is often reduced in the brains of individuals with Alzheimer's disease, and that it is involved in the progression of neurodegeneration in this disease. Similarly, AQP6 (KID) has also been shown to be involved in the regulation of blood sugar levels in individuals with diabetes, and that it may play a role in the progression of diabetes.

In conclusion, AQP6 (KID) is a water channels protein that is expressed in various body tissues and organs, and is involved in a wide range of physiological processes that are essential for proper growth, development, and survival. Recent studies have identified AQP6 (KID) as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, diabetes, and cardiovascular diseases. The unique properties of AQP6 (KID), such as its high expression in the brain and its role in water homeostasis, make it an attractive target for drug development. Further research is needed to fully understand the role of AQP6 (KID) in disease and to develop effective treatments.

Protein Name: Aquaporin 6

Functions: Forms a water-specific channel that participates in distinct physiological functions such as glomerular filtration, tubular endocytosis and acid-base metabolism

The "AQP6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AQP6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets